Skip to main content
SpringerLink
Log in

A clinical evaluation of flurbiprofen LAT and piroxicam gel: A multicentre study in general practice

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

A prospective, randomized, multicentre, open, crossover study of the comparative efficacy, tolerability and acceptability of two topical nonsteroidal anti-inflammatory drug (NSAID) therapies, flurbiprofen local-action transcutaneous (LAT) patch (40 mg b.d.) and piroxicam gel (3 cm, 0.5% q.d.s), was conducted in general practice in the UK in 137 men and women with soft-tissue rheumatism of the shoulder or elbow (e.g. epicondylitis, tendinitis, bursitis and adhesive capsulitis). Patients received one therapy for 4 days before crossing over to the other NSAID for a further 4 days, followed by 6 days of their preferred therapy. Clinical assessment of severity of pain, tenderness and overall clinical condition was carried out at baseline and after 4, 8 and 14 days. Patients self-assessed the severity of pain during the day and at night, and also the quality of their sleep during each treatment phase.

More patients showed a greater improvement in all of the clinical assessments of efficacy following treatment with flurbiprofen LAT during the crossover phase. There was a statistically significant reduction in the severity of pain, the principal measure of efficacy, in favour of flurbiprofen LAT: 42% of patients showed greater improvement with flurbiprofen LAT compared with 26% who showed a greater improvement with piroxicam gel (p=0.012; n=131, intent-to-treat). Eligible dataset (n=126) analysis revealed statistically significant differences in favour of flurbiprofen LAT in the severity of lesion tenderness (p=0.03) and the overall change in clinical condition (p=0.04) compared with baseline status. Superior efficacy for flurbiprofen LAT was also indicated in the patients' assessment at the end of the crossover phase (day 8), at which 69% chose to continue treatment with flurbiprofen LAT compared with only 31% of patients who chose piroxicam gel (n=126; p<0.001). There were, in addition, statistically significant differences in favour of flurbiprofen LAT in assessments for night pain (p<0.001), quality of sleep (p=0.004) and the patients' overall opinion of treatment (p<0.001). Both treatments were well tolerated with a low incidence of mainly local adverse events. These results showed that flurbiprofen LAT had a greater efficacy than piroxicam gel, and was also preferred by patients in the treatment of painful soft-tissue rheumatism of the shoulder and elbow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Famaey, J.P. Correlation of plasma levels, NSAID and therapeutic response. Clin Rheumatol 1985, 4, 124–132.

    PubMed  Google Scholar 

  2. Radermacher, J., Jentsch, D., Scholl, M.A., Lustinetz, T., Frölich, J.C. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991, 31, 537–541.

    PubMed  Google Scholar 

  3. Ginsberg, F., Famaey, J.P. Double-blind, randomized crossover study of the percutaneous efficacy and tolerability of a topical indomethacin spray versus placebo in the treatment of tendinitis. J Int Med Res 1991, 19, 131–136.

    PubMed  Google Scholar 

  4. Bouchier-Hayes, T.A., Rotman, H., Darekar, B.S. Comparison of the efficacy and tolerability of diclofenac gel (Voltarol Emulgel) and felbinac gel (Traxam) in the treatment of soft tissue injuries. Br J Clin Pract 1990, 44, 19–20.

    Google Scholar 

  5. Atra, E., Metz, C.A., Brown, B.L., Teoh, K. Flurbiprofen versus diclofenac for the treatment of osteoarthritis of the knee. Ann Pharmacother 1990, 24, 920–923.

    Google Scholar 

  6. Stubbs, D.F., Freeman, B.E., Jonson, J.H. Efficacy of flurbiprofen for non-arthritic pain. Curr Ther Res 1989, 46, 1179–1195.

    Google Scholar 

  7. Grant, M., Walter, J., Wojtulewski, J.A. A double-blind parallel group comparison of flurbiprofen and indomethacin in the long term treatment of osteoarthrosis of the knee. Br J Clin Pract 1980, 37, suppl 9, 92–94.

    Google Scholar 

  8. Buchanan, W.W., Kassam, Y.B. European experience with flurbiprofen. A new analgesic, anti-inflammatory agent. Am J Med 1986, 80, 145–152.

    PubMed  Google Scholar 

  9. Taburet, A.M., Singlas, E. Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers. J Clin Pharm Ther 1995, 20, 101–107.

    PubMed  Google Scholar 

  10. Sugawara, S. A study of the concentration in the synovial fluid and tissues of patients treated with the transdermal topical application of flurbiprofen (FP-A). Therap Res 1987, 6, 289–294.

    Google Scholar 

  11. Poul, J., West, J., Buchanan, N., Grahame, R. Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. Br J Rheumatol 1993, 32, 1000–1003.

    PubMed  Google Scholar 

  12. Memeo, A., Garofoli, F., Peretti, G. Evaluation of the efficacy and tolerability of a new topical formulation of flurbiprofen in acute soft tissue injuries. Drug Invest 1992, 4, 441–449.

    Google Scholar 

  13. Aoki, T., Sugawara, S., Fujimaki, Y. et al. Clinical evaluation of topical application of flurbiprofen (FP-A) as a treatment for periarthritis scapulohumeralis-collaborative double-blind test compared with the control. Jap J Inflamm 1989, 9, 335–344.

    Google Scholar 

  14. Russell, A.L. Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double-blind study comparing efficacy and safety. Clin Invest Med 1991, 14, 35–43.

    PubMed  Google Scholar 

  15. Hills, M., Armitage, P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979, 8, 7–20.

    PubMed  Google Scholar 

  16. Hollander, M., Wolfe, D.A. Nonparametric Statistical Methods. New York: Wiley, 1973, 67–75.

    Google Scholar 

  17. Armitage, P., Berry, G. Statistical Methods in Medical Research, 2nd ed. Oxford: Blackwell, 1987, 106–108.

    Google Scholar 

  18. Shapiro, S.S., Wilk, M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52, 591–611.

    Google Scholar 

  19. Brown, M.B., Forsyth, A.B. Robust tests for the equality of variances. J Am Stat Assoc 1974, 69, 364–367.

    Google Scholar 

  20. Armitage, P., Berry, G. Statistical Methods in Medical Research, 2nd ed. Oxford: Blackwell, 1987, 120–123.

    Google Scholar 

  21. Kay, E., Petty, D. Topical NSAIDs. Curr Pract Pharm Ther, 1991, 3(8), 5–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Practice, University of Aberdeen, AB9 2AY, U.K.

    L. D. Ritchie M.D. (FRCP (Ed.), FRCGP)

Authors
  1. L. D. Ritchie M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

On behalf of the General Practice Research Group: P.J.M. Milroy, P. Roylance, G. Hamilton, F.G. De, L. Wright, M.M.G.B. Scott, S. R. Fisher, B.A. Hakin, P.A. Vakil, J.A.G. Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritchie, L.D. A clinical evaluation of flurbiprofen LAT and piroxicam gel: A multicentre study in general practice. Clin Rheumatol 15, 243–247 (1996). https://doi.org/10.1007/BF02229701

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02229701

Key words

Search

Navigation